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ABSTRACT
Pluripotency is regulated by a network of transcription factors that
maintain early embryonic cells in an undifferentiated statewhile allowing
them to proliferate. NANOG is a critical factor for maintaining
pluripotency and its role in primordial germ cell differentiation
has been well described. However, Nanog is expressed during
gastrulation across all the posterior epiblast, and only later in
development is its expression restricted to primordial germ cells. In
this work, we unveiled a previously unknown mechanism by which
Nanog specifically represses genes involved in anterior epiblast lineage.
Analysis of transcriptional data from both embryonic stem cells and
gastrulating mouse embryos revealed Pou3f1 expression to be
negatively correlated with that of Nanog during the early stages of
differentiation. We have functionally demonstrated Pou3f1 to be a
direct target of NANOG by using a dual transgene system for the
controlled expression of Nanog. Use of Nanog null ES cells further
demonstrated a role for Nanog in repressing a subset of anterior
neural genes. Deletion of a NANOG binding site (BS) located nine
kilobases downstream of the transcription start site of Pou3f1
revealed this BS to have a specific role in the regionalization of the
expression of this gene in the embryo. Our results indicate an active
role of Nanog inhibiting neural regulatory networks by repressing
Pou3f1 at the onset of gastrulation.
This article has an associated First Person interview with the joint first
authors of the paper.
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INTRODUCTION
Pluripotency is a steady state in which cells can self-renew and remain
undifferentiated, retaining the capacity to give rise to derivatives of
any germ layer. This cell state is maintained by an intricate gene
regulatory network (GRN) that is tightly regulated by a core set of
transcription factors (TF): NANOG, OCT4 and SOX2 (Navarro et al.,
2012; Rodda et al., 2005; Teo et al., 2011; Trott and Martinez Arias,
2013). These three TFs are involved in establishing and maintaining
embryonic pluripotency, both in the blastocyst and in cultured
embryonic stem (ES) cells (Chambers and Tomlinson, 2009). This
GRN regulates pluripotency by repressing genes involved in
differentiation and activating other genes important for pluripotency
(Navarro et al., 2012; Thomson et al., 2011). The same GRN also
initiates the process of exiting pluripotency by responding to extrinsic
and intrinsic signals and changing the regulatory regions and partners
these factors bind to (Hoffman et al., 2013; Kalkan and Smith, 2014;
Mohammed et al., 2017; Pfeuty et al., 2018).
ES cells can be maintained in different stages of differentiation, the
most studied being ground, naïve and primed pluripotent cells (Joo
et al., 2014; Morgani et al., 2017; Nichols and Smith, 2009). These
states are defined so that they can bemaintained and passaged in vitro
indefinitely: the first with Leukemia Inhibitory Factor (LIF) and 2i
(MEK and GSK3 inhibitors), the second with LIF and serum (Ying
et al., 2008), and the latter with Activin and FGF (Tesar et al., 2007).
However, while ground and naïve pluripotent cells contribute to all
embryonic lineages in blastocyst chimeras, cells in the primed state
have lost this potential (Festuccia et al., 2013). In ground pluripotent
ES cells, NANOG is highly and homogeneously expressed, while in
the primed ES cells NANOG expression levels fluctuate. Transition
between these two cell states determines the onset of differentiation.
In fact, it has been demonstrated that lowering levels of Nanog
expression in ES cells triggers differentiation and its overexpression is
sufficient to maintain the cells in a LIF-independent pluripotent state
(Chambers et al., 2007). In spite of multiple studies that have
addressed ES cell differentiation (Mendjan et al., 2014;
Radzisheuskaya et al., 2013; Thomson et al., 2011), the role of
NANOG during the exit from pluripotency in vivo is still not
well understood (Osorno et al., 2012; Tam and Behringer, 1997).
During implantation, Nanog disappears from the epiblast and is
re-expressed in the proximal posterior region of the epiblast after
implantation, the region in which gastrulation starts (Hart et al.,
2004). Thus, we hypothesized that Nanog not only has a role in
pluripotency maintenance, but also in defining lineage commitment
upon gastrulation (Mendjan et al., 2014). We have recently shown
that, at the onset of gastrulation, Nanog has a determinant role in
repressing primitive hematopoiesis and Hox genes expression
(Lopez-Jimenez et al., 2019 preprint; Sainz de Aja et al., 2019).
To gain further insight into the roles of Nanog beyond
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NANOG in different ES cell lines and in mouse embryos. By
combining the analysis of different RNA-seq data sets, we found
that Pou3f1 expression is regulated by Nanog. Pou3f1, which
encodes a TF involved in promoting neural fate, is initially
expressed throughout the epiblast at early implantation stages
(Song et al., 2015; Zhu et al., 2014). However, at the onset of
gastrulation when Nanog is re-expressed in the embryo
(Yamaguchi et al., 2005), its expression becomes quickly
restricted to the anterior epiblast. While the role of POU3F1 in
antagonizing extrinsic neural inhibitory signals is well known
(Zhu et al., 2014), little information is available about the
transcriptional regulation of this gene in the early stages of
gastrulation. By deleting NANOG binding sites located next to
the Pou3f1 locus, we observed that Nanog prevents the
expression of Pou3f1 in the posterior region of the gastrulating
embryo. Therefore, we present a previously unknown
mechanism by which Nanog constrains Pou3f1 expression to
the anterior region of the embryo, a necessary step for its role in
neural development.
RESULTS
Lack of Nanog leads to upregulation of anterior genes at the
exit from naïve pluripotency
To explore the role of Nanog and to identify putative targets during
the transition from pluripotency to lineage specification, we
analyzed expression changes in ES cells mutant for Nanog and
compared them to the parental wild-type ES cell line as control
(Chambers et al., 2007). Cells were first cultured with 2i/LIF/KOSR
and subsequently changed to serum to induce exit from
pluripotency (Heo et al., 2005; Martin Gonzalez et al., 2016). To
follow the earliest events taking place, we sampled the cultures at 0,
12, and 24 h (Fig. 1A; Table S1). Then, we performed RNA-seq and
selected genes that changed their expression dynamics from 0–24 h.
We identified genes repressed by Nanog as those with stable
expression in control ES cells but increased expression in Nanog
KO cells along time (Fig. 1B), and genes that are positively
regulated by Nanog as those activated in controls but unchanged in
mutant cells (Fig. 1C).
Principal component analysis (PCA) of the RNA-seq data
showed a clear separation of the samples based on the genotype
of the cells (dim1, Fig. S1) and timing of differentiation (dim2,
Fig. S1). The genotypic difference resulted in close to 43%
variability, whereas timing of differentiation explained 26% of the
variability. Interestingly, the comparison at time 0 between control
and Nanog KO ES cells showed minimal differences in the
expression of core pluripotency genes like Oct4 or Sox2 (Fig. 1D).
The similarities between Nanog KO and wild-type cells in the
pluripotent stage agree with previous observations on the
dispensability of Nanog at the pluripotent state (Chambers et al.,
2007). We analyzed changes in gene expression, factoring in their
expression over time, and identified two clusters with the predicted
pattern of change (Fig. 1E,F). Genes that are upregulated in
differentiating Nanog mutant cells but not in controls are enriched
in neural specifiers such as Pou3f1, Sox8 or Fgf3 (Fig. 1G;
Table S1A) (Bell et al., 2000; O’Donnell et al., 2006; Zhu et al.,
2014). On the other hand, genes that fail to be upregulated in
mutant cells are involved in mesoderm development, such as
Mef2c, Hand2 or Tbx2 (Fig. 1G; Table S1B). This analysis
indicates that Nanog might be involved in the repression of genes
implicated in the development of the anterior-neural fate while
promoting posterior-mesodermal fate at the exit from pluripotency
in ES cells.
RNA-seq data reveal Pou3f1 as a primary target for
repression by NANOG in gastrulating mouse embryos
To further explore the putative role of Nanog in neural anterior fate
in vivo, we took advantage of published E6.5 embryo single-cell
RNA-sequencing (scRNA-seq) data (Mohammed et al., 2017;
Scialdone et al., 2016). E6.5 is the stage at which Nanog is
re-expressed in the posterior part of the mouse embryo (Hart et al.,
2004) and several genes including Sox2 or Pou3f1 are already
restricted to the epiblast. We merged two single cell RNA-seq
expression data sets and selected those single cells expressing
Nanog above 0.4 cpm. The expression of all the genes with 0.4 cpm
in at least four cells of at least two samples were adjusted with a
linear mixed effect model to the expression of Nanog (Tables S1C,
S1D). Next, we established the correlation of all expressed genes to
that ofNanog (Fig. 2A; Tables S1C,D). These results confirmed our
previous observations in cultured cells. Genes that correlated
positively with Nanog were related to gastrulation and mesoderm
formation, such as Fgf8, Nodal or Eomes (Fig. 2B; Table S1C).
Genes that negatively correlated with Nanog include Pou3f1 and
other neural genes such as Nav2 (Fig. 2B; Fig. S2A, Table S1D).
Other early anterior genes, such as Sox2, did not show any
correlation with Nanog levels (Fig. S2B), suggesting that Nanog
might not have a broad impact on anterior specification, but rather
has a specific effect on certain genes. Interestingly, among the
negatively correlated genes we also found Utf1 (Fig. 2B), a
pluripotency associated gene that is restricted to the anterior region
of the embryo during gastrulation and to extraembryonic tissues
(Okuda et al., 1998). Enrichment analysis of the clustered genes
matching the Jansen tissues gene set library (Chen et al., 2013;
Kuleshov et al., 2016), allowed us to observe that negatively
correlated genes included many genes related to neural development
(spinal cord, frontal lobe), and with a lower z-score than endodermal
tissues (gut, intestine) (Fig. S2C). Genes that positively correlate
with Nanog expression included many genes related to mesodermal
tissues (monocyte, B lymphoblastoid cell, bone) (Fig. S2D).
We next addressed the effect of expressing Nanog throughout the
early embryo when using an inducible tetON transgenic model
(Nanogtg) in which Nanog expression is induced by the
administration of doxycycline (dox) (Piazzolla et al., 2014). We
analyzed bulk RNA-seq data of embryos where Nanogwas induced
from E4.5 to E7.5 and examined changes in gene expression using
untreated females of the same genotype as controls (Lopez-Jimenez
et al., 2019 preprint). In this dataset, many genes involved in the
early aspects of embryo pattering, such as Hox genes, were
downregulated (Lopez-Jimenez et al., 2019 preprint), but the most
strongly downregulated gene when Nanog was expressed
throughout the early embryo was Pou3f1 (Fig. 2C). The
expression of other anterior neural genes, for example Sox2,
Hesx1 or Zic3, was not changed. We confirmed these observations
by wholemount in situ hybridization of treated and untreated
E7.5 Nanogtg embryos. Induction of Nanog led to a partial
downregulation of Pou3f1 in the anterior epiblast of treated
embryos, while expression of Sox2 was unchanged (Fig. 2D).
Interestingly, when Nanogtg embryos were recovered at E9.5 after
treatment with dox from E6.5, they presented craniofacial defects
(white arrowheads) that might be a direct consequence of the
deregulation of yet to be identified Nanog target genes (Fig. S2E).
We merged the data from these previous transcriptomic analysis,
finding for example that genes whose expression positively
correlated with that of Nanog in E6.5 single cells and that
were upregulated in dox-treated Nanog tg embryos were mostly
related to early gastrulation and mesoderm specification, such as
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Eomes, Fgf8, Tdgf1 (Cripto) or Mixl1. However, only three
genes were shared by those upregulated in Nanog KO ES cells
during early differentiation, genes having a significant negative
correlation with Nanog in E6.5 single cell transcriptomics, and
that were downregulated in E7.5 Nanog gain-of-function
embryos: Pou3f1, Lrp2 and Clic6 (Fig. 2E). Interestingly, Lrp2
andClic6 are expressed in primitive endoderm and late derivatives
(Gerbe et al., 2008; Sherwood et al., 2007), which are lineages
in which Nanog has a well-defined negative regulatory role
(Chazaud et al., 2006; Dietrich and Hiiragi, 2007; Yamanaka
et al., 2010). Therefore, Pou3f1 is a prime candidate to be a direct
target of Nanog, mediating its role in suppressing anterior
epiblast fate.
Nanog expression impairs neural differentiation in vitro
To confirm whether Nanog is blocking anterior fate progression, we
derived ES cells from the Nanogtg line and differentiated them
towards anterior neural fate (Gouti et al., 2014, 2017), culturing
them with or without dox for up to 6 days. Analysis of gene
expression by RT-qPCR showed that upon induction of Nanog,
neural specification genes (Pou3f1, Sox1, Pax6 and Otx2) were not
upregulated during the differentiation process to the same extent as
in control-treated cells. Sox2, which has roles both in pluripotency
and in early neural development, showed a similar pattern of
expression by qPCR in both Nanogtg +dox and −dox (Fig. 3A).
Immunofluorescence of TUJ1, revealed lack of differentiation at a
protein level in the differentiation of Nanogtg cells treated with dox
Fig. 1. Early transcriptional response to Nanog at the naïve to primed transition. (A) Schematic representation of the experimental setup to address
transcriptional changes of control and Nanog mutant ES cells as they transition from the naïve to the primed state. Samples in triplicate were taken
in naïve conditions (2i+LIF) and after 12 or 24 h of growth in serum. (B,C) Predicted outcome of the change in expression of genes repressed (B) or
activated (C) by Nanog during priming of ES cells. (D) Volcano plot depicting gene expression changes of control ES cells compared to Nanog KO cells
in naïve conditions (0 h). In blue, genes upregulated in Nanog KO cells, and in orange genes upregulated in control cells (0.5<LogFC<0.5). In grey genes
that have less than [0.5] Log Fold Change (LogFC). Core pluripotency factors are indicated. (E,F) Graphs showing the normalized expression values
(average CPM) of genes that are upregulated in Nanog mutant cells across time but not in controls (E, repressed by Nanog), or genes that are
upregulated in control cells but not in Nanog mutant (F, activated by Nanog). (G) Heatmap comparing the expression profiles of both set of genes, with
representative examples of neural (top) or mesodermal (bottom) genes included in these sets indicated on the right. The set of 89 genes upregulated in
NanogKO across time is represented in the upper section of the heatmap. The set of 55 genes upregulated in control wild-type cells across time is
represented in the lower section of the heatmap.
3
RESEARCH ARTICLE Biology Open (2019) 8, bio046367. doi:10.1242/bio.046367
B
io
lo
g
y
O
p
en
 at Cambridge - Zoology on December 9, 2019http://bio.biologists.org/Downloaded from 
(Fig. 3B). When cells were differentiated towards a more posterior
neural fate by treatment with high doses of retinoic acid (Gouti et al.,
2014, 2017), differences in the expression of neural markers were
less marked, although following a similar trend (Fig. S3). We also
observed a reduction in the expression of Hoxa1, a marker for
posterior neural (hindbrain) fate (Fig. S3), in line with recent
findings (De Kumar et al., 2017; Lopez-Jimenez et al., 2019
preprint). These results indicate that during neural differentiation,
Nanog prevents the upregulation of genes important for neural
specification.
Fig. 2. See next page for legend.
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A distal NANOG-binding element represses Pou3f1
expression in the posterior epiblast
The evidence presented so far suggests that Pou3f1 is likely a direct
transcriptional target of NANOG during anterior-posterior axis
specification in the epiblast. To explore this possibility, we analyzed
published ChIP-seq data for NANOG binding in ES and epiblast-
like cells (EpiLCs) (Murakami et al., 2016). This work describes a
broad resetting of NANOG-occupied genomic regions in the
transition from ES cells to EpiLCs, resembling the developmental
progress from the naïve inner cell mass of the blastocyst to the
primed epiblast at gastrulation. We examined the Pou3f1 locus and
identified three prominent regions of NANOG binding at 11.5 and
9 kilobases (kb) upstream and 9 kb downstream from the
transcription start site. Interestingly, NANOG binds these regions
in EpiLC but not in ES cells, suggestive of a specific input ofNanog
on Pou3f1 in the epiblast but not at earlier pluripotent stages
(Fig. 4A).
We hypothesized that the deletion of the NANOG bound regions
would de-repress Pou3f1 and therefore expand its expression domain
towards the posterior region of the embryo at E6.5. To investigate this
hypothesis, we separately deleted each of the three NANOG bound
regions we identified at the Pou3f1 locus by CRISPR/Cas9 genome
editing in a transient transgenic embryo assay. Embryosmicroinjected
with Cas9-gRNAs ribonucleoproteins were recovered at E6.5,
processed for wholemount in situ hybridization, and subsequently
genotyped for the expected deletion (Fig. S4). This assay showed that
only deletion of the +9 kb downstream region caused a reproducible
change inPou3f1 expression, consisting in a posterior expansion of its
expression domain in the epiblast (Fig. 4B,C). To further confirm this
observation, we generated a stable mouse line carrying the deletion of
the +9 kb NANOG bound region (Fig. 4D). Mice homozygous for
the deletion were viable and fertile, which was not completely
unexpected as homozygous null Pou3f1 mice survive up to birth
(Bermingham et al., 1996). We crossed mice heterozygous and
homozygous for the deletion and compared littermates for the
expression of Pou3f1 by wholemount in situ hybridization. We
observed that three out of five homozygous embryos presented a
phenotype of posterior expansion while none of the heterozygous
embryos did so (Fig. 4E). These results show that the +9 kb NANOG
bound region is important for the restriction of Pou3f1 expression to
the anterior epiblast.
DISCUSSION
The transition from pluripotency towards early differentiation
that occurs during the initial stages of mammalian embryonic
development can be recapitulated in vitro, at least partially, under
defined culture conditions (Hackett and Surani, 2014; Nichols and
Smith, 2009). This provides an opportunity to study and follow
different pluripotent states, as cells move from the naïve or ground
state, equivalent to the epiblast of the blastocyst, to a primed state that
more closely resembles the early post-implantation embryo, where
first lineage decisions take place (Yang et al., 2019). The role of a core
set of transcription factors (that includes OCT4, NANOG or SOX2)
controlling the establishment and maintenance of embryonic
pluripotency has been extensively studied (Chambers and
Tomlinson, 2009). Moreover, recent studies indicate that these same
factors can play important roles in regulating the exit from
pluripotency towards committed states (Festuccia et al., 2013) as
well as later developmental decisions in the embryo (Aires et al.,
2016; Lopez-Jimenez et al., 2019 preprint; Sainz de Aja et al., 2019).
In this work, we sought to capture the first steps in the
differentiation of naïve ES cells to assess the role of Nanog in the
exit from pluripotency. We observed that globally, Nanog represses
the differentiation of the anterior fate while promoting posterior
differentiation. In an effort to identify direct transcriptional targets
of NANOG in this process, we merged three sets of data:
transcriptomic data from naïve-to-primed differentiation of Nanog
mutant ES cells; single-cell RNA-seq data from E6.5 embryos
(Mohammed et al., 2017; Scialdone et al., 2016); and transcriptional
analysis of the forced expression ofNanog in E7.5 embryos (Lopez-
Jimenez et al., 2019 preprint). Only three genes were identified that
met the requirements to be negatively regulated by Nanog
(upregulated during differentiation of Nanog KO cells, negatively
correlated with Nanog in scRNA-seq data, and downregulated upon
Nanog expression in embryos). Two of them, Lrp2 and Clic6, are
most prominently expressed in the primitive endoderm and later in
other endoderm derivatives (Nowotschin et al., 2019), and in fact
LRP2 had been previously identified as a marker of primitive
endoderm precursors of the blastocyst (Gerbe et al., 2008). This fits
well with the known role of Nanog in the epiblast/primitive
endoderm decision occurring in the preimplantation embryo
(Bassalert et al., 2018; Frankenberg et al., 2011) and suggests that
Lrp2 and Clic6 could be directly repressed by NANOG in epiblast
cells of the blastocyst.
The third gene identified as a potential NANOG target is Pou3f1.
This gene encodes a POU family transcription factor, initially
expressed throughout the epiblast of E6.5 embryos and later
restricted to the anterior epiblast at E7.5 and afterwards, to the
anterior neural tube (Iwafuchi-Doi et al., 2012; Zwart et al., 1996).
Pou3f1 has also been shown to drive the progression of neural
differentiation both in ES cells and in epiblast like stem cells
(EpiLCs) through the activation of intrinsic neural lineage genes
such as Sox2 or Pax6 (Song et al., 2015; Zhu et al., 2014). Pou3f1 is
strongly downregulated in embryos in which we induce the
expression of Nanog, and we observe the same in ES cells
differentiated towards neural fates. Interestingly, this effect is more
pronounced when ES cells are directed to anterior/forebrain
identities rather than posterior/hindbrain fates (Gouti et al., 2014;
2017), resembling the dynamics of Pou3f1 expression in the
developing neural tube (Zwart et al., 1996).
Analysis of published ChIP-seq data in ES and EpiL cells
(Murakami et al., 2016) allowed us to identify three genomic
regions that could be mediating the transcriptional repression of
Pou3f1 by NANOG. It is noteworthy that these sites are not bound
Fig. 2. Integration of different RNA-seq datasets to identify
transcriptional targets of Nanog. (A) Schematic representation of an E6.5
embryo indicating the diminishing levels of Nanog towards the distal region
of the embryo by a black triangle. Red and green triangles represent the
positive and negative correlations, respectively, between Nanog and any
other given gene. (B) Correlation values of the genes that show the highest
statistical correlation with Nanog (green, negative; red, positive) in two
different mouse embryo single cell RNA-seq data sets (Mohammed et al.,
2017; Scialdone et al., 2016). (C) List of the most downregulated genes
in Nanogtg E7.5 embryos where expression of Nanog was induced (dox
treated) as compared to controls (Lopez-Jimenez et al., 2019 preprint). Bars
indicate the log fold change (LFC) of the differences in expression between
Nanog induced and control embryos. (D) In situ hybridization for Nanog,
Pou3f1 and Sox2 of Nanogtg embryos treated (+dox) or untreated (−dox)
with doxycycline. n=5. Scale bars: 300 µm. (E) Venn diagram showing the
intersection of the different RNA-seq datasets analyzed. In blue are all
genes significantly upregulated upon Nanog loss of function in ES cells
during transition to the primed state (this work); in green, genes that
are negatively correlated with Nanog in embryo single cell RNA-seq
(Mohammed et al., 2017; Scialdone et al., 2016); and in purple, genes
downregulated upon expression of Nanog in E7.5 embryos (Lopez-Jimenez
et al., 2019 preprint). Genes found in all three groups are indicated.
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in ES cells but only in EpiLCs, indicating that NANOG is not
simply repressing Pou3f1 as part of the core pluripotency program,
but involved in fine-tuning the timing of its expression once
differentiation programs are initiated at the primed state. We
detected expansion of Pou3f1 expression to the posterior epiblast
only when the +9 kb region was deleted. However, this does not rule
Fig. 3. Nanog impedes anterior neural differentiation of ES cells. (A) Expression of selected neural markers, as measured by RT-qPCR, during 6 days
of differentiation to anterior neural fate of Nanogtg ES cells with (+dox, blue) or without (−dox, gray) doxycycline. n=3 at each time point; *P<0.01; **P<0.001;
***P<0.0001, by Student’s t-test. (B) Immunofluorescence at day 6 of anterior neural differentiation of Nanogtg ES cells with (+dox) or without (−dox)
showing nuclei stained with DAPI in blue, and TUJ1 in green. Scale bars: 100 µM.
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out a possible input of the other two regions (−11.5 kb and −9 kb);
had all three regions been deleted in the same embryo, we might
have observed a more robust de-repression of Pou3f1.
The results we describe here, together with our previous
observations regarding the function of Nanog in primitive
hematopoiesis (Sainz de Aja et al., 2019), suggest that Nanog has
an active role in the primed epiblast as a brake for ongoing lineage
determination. Apparently, this occurs through well-known neural
(Pou3f1) or mesodermal (Tal1; Sainz de Aja et al., 2019) specifiers,
but it is tempting to speculate, based on our observations for Lrp2
and Clic6, that it is also occurring in endodermal lineages. Only
when Nanog expression is extinguished, transcriptional repression
of these epiblast-specific targets lifted, and differentiation allowed
to proceed. Understanding the regulatory mechanism that controls
the re-expression of Nanog in the epiblast (Hart et al., 2004) and
how it is definitively silenced will allow us to better understand how
pluripotency is dismantled and how particular lineage specific
programs come to be deployed.
Fig. 4. Deletion of a NANOG bound region in the Pou3f1 locus expands its expression in the posterior epiblast. (A) Pou3f1 genomic region on
chromosome 4 showing binding of NANOG as determined by ChIP-seq in ES cells (ESC) or EpiLC after one (D1) or two (D2) days of differentiation D2.
Data was obtained from Murakami et al. (2016). (B) Percentage of embryos without (wild-type genotype) or with the expected deletion (del. genotype)
recovered at E6.5 after microinjection of Cas9 and pairs of sgRNAs targeting each of the three NANOG bound regions in the Pou3f1 locus (−11.5 kb, −9 kb,
+9 kb). In gray, percentage of embryos showing a normal expression pattern of Pou3f1 (wild-type phenotype) and in blue those showing expansion of
expression in the posterior region of the epiblast (expanded expression phenotype). Below, Fisher’s exact test P-value for differences of expression patterns
(phenotypes) between genotypes. (C) In situ hybridization for Pou3f1 in E6.5 embryos showing the normal expression pattern (wild-type phenotype) and the
extended expression in the posterior epiblast (white arrow) due to the deletion by transient transgenics of the +9 kb NANOG-bound genomic region
(expanded expression phenotype). The extent of Pou3f1 expression is indicated by a dashed white line. (D) Sequence of the +9 kb NANOG-bound genomic
region from Pou3f1 (mm10, chr4:124,666,818-124,667,185). gRNAs are shown in blue, the consensus NANOG binding motif in black, and the region
deleted in the stable +9 kb deletion mouse line in grey. (E) In situ hybridization for Pou3f1 in heterozygous (left) and homozygous (right) E6.5 embryos from
the +9 kb deletion mouse line. White arrowhead indicates the posterior expansion in expression observed in homozygote embryos. The number of embryos
showing an expansion of Pou3f1 expression is indicated for each genotype. Scale bars (C,E): 300 µm.
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MATERIALS AND METHODS
ES cell culture and differentiation
ES cells were maintained in serum-free conditions with Knockout serum
replacement (Thermo Fisher Scientific), LIF (produced in-house), and 2i
(CHIR-99021, Selleckchem; and PD0325901, Axon) over inactive mouse
embryonic fibroblast (MEFs). The NanogKO (BT12) and their parental wild-
type control (E14Tg2a) ES cells were kindly provided by Ian Chambers
(MRC Centre for Regenerative Medicine, Edinburgh) and Austin Smith
(Wellcome-MRC Cambridge Stem Cell Institute) (Chambers et al., 2007).
The Nanog gain-of-function ES cells were derived from the Nanog/rtTA
mouse line following standard procedures (Nagy et al., 2014). Karyotyping of
the obtained lines was performed by the Pluripotent Cell Technology Unit
at CNIC.
Nanogtg ES cells were differentiated to anterior (forebrain) or posterior
(hindbrain) neural lineages as described (Gouti et al., 2014, 2017). Cells
were grown in N2B27 media supplemented with 10 ng/ml bFgf (R&D) for
the first 3 days (d1–d3), and then from day 3 to 6 in N2B27 without growth
factors for forebrain differentiation, or in N2B27 supplemented with 10 nM
retinoic acid for hindbrain differentiation. A Tuj1 monoclonal antibody
(Promega #G7121, dilution 1:100) was used to assess neuronal
differentiation. All cell lines have been tested for contamination at the
CNIC Cell Culture Unit.
RNA-seq
RNA from NanogKO ES cells and their parental line was extracted using the
RNeasy Mini Kit (Qiagen) and then reverse transcribed using the High
Capacity cDNA Reverse Transcription Kit (Applied Biosystems). Library
preparation (New England Biolabs Nest Ultra RNA library prep Kit) and
single read next generation sequencing (Illumina HiSeq 2500) were
performed at the Genomics Unit at Centro Nacional de Investigaciones
Cardiovasculares (CNIC).
Sequencing reads were processed by means of a pipeline that used FastQC
(http://www.bioinformatics.babraham.ac.uk/projects/fastqc) to asses read
quality, and Cutadapt v1.3 (Martin, 2011) to trim sequencing reads,
eliminating Illumina adaptor remains and to discard reads that were shorter
than 30 bp. The resulting reads were mapped against the mouse transcriptome
(GRCm38 assembly, Ensembl release 76) and quantified using RSEM
v1.2.20 (Li and Dewey, 2011). Raw expression counts were processed with an
analysis pipeline that used Bioconductor packages EdgeR (Robinson et al.,
2010) for normalization (using TMM method) and differential expression
testing, and ComBat (Johnson et al., 2007) for batch correction. Only genes
expressed at a minimal level of 1 count per million, in at least three samples,
were considered for differential expression analysis. Changes in gene
expression were considered significant if their Benjamini and Hochberg
adjusted P-value (FDR) was lower than 0.05.
RNA-seq data is available at the Gene Expression Omnibus (GEO)
database under accession number GSE138818.
Bioinformatic analysis
Two data sets from different mouse embryo single cell RNA-seq experiments
(Mohammed et al., 2017; Scialdone et al., 2016) were normalized by quantiles
and batch corrected. After merging the two datasets, genes with zero-variance
were eliminated and counts were log2 transformed and scaled. Then, datasets
were normalized using the quantiles method and batch corrected. Single cell
clustering patterns were visualized after dimensionality reduction with the R
package Rtsne. For correlation of genes with Nanog we used the slope of the
line adjusted to the points per sample. For plotting we used ggPlot package
from R. We separated the plots by sample. Statistical analysis was developed
in R. RNA-seq data from E7.5 Nanogtg embryos was previously described
(Lopez-Jimenez et al., 2019 preprint). The intersection analysis of the genes
coming from different RNA-seq datasets was performed with the web tool
from Bioinformatics and Evolutionary Genomics (http://bioinformatics.psb.
ugent.be/webtools/Venn/).
RT-qPCR assays
RNAwas isolated from ESCs using the RNeasy Mini Kit (Qiagen) and then
reverse transcribed using the High Capacity cDNA Reverse Transcription Kit
(Applied Biosystems). cDNA was used for quantitative-PCR (qPCR) with
Power SYBR® Green (Applied Biosystems) in a 7900HT Fast Real-Time
PCR System (Applied Biosystems). Primers for qPCR detailed in Table S2.
Transgenic analysis and mouse models
For the generation of transgenic embryos, 7-week-old F1 (C57Bl/6xCBA)
females were superovulated to obtain fertilized oocytes as described
(Nagy et al., 2014). Viable one-cell embryos were microinjected into
the pronucleus with commercially available Cas9 protein (30 ng/µl;
PNABio) and guide RNAs (sgRNA; 25 ng/µl; Sigma-Aldrich). All
those components were previously hybridized in solution to generate
ribonucleoprotein complexes. First, we incubated 100 ng/µl of trans-
activating crRNA (tracrRNA) and sgRNA for 5 min at 95°C and then for
10 min at room temperature (RT). We then incubated the sgRNAs with
the Cas9 for 15 min at RT and stored at 4°C. Injection buffer consisted of
Tris 50 nM pH7.4, EDTA 1 nM, H2O embryo tested and was filtered
through a 0.22 um filter. After injection, embryos were cultured in M16
(Sigma-Aldrich) covered with mineral oil (Nid Oil, EVB) up to the two-
cell stage. Living embryos were then transferred into a pseudopregnant
CD1 female, previously crossed with a vasectomized male. Embryos were
recovered at E6.5 for further analysis, or allowed to progress in order to
establish a stable line carrying the deletion of the +9 kb region. sgRNA
were designed with an online tool (http://crispr.mit.edu/). Details of the
sequences for the sgRNAs and primers used for genotyping are shown in
Table S2.
We obtained the Nanog/rtTA mouse line (R26-M2rtTA;Col1a1-tetO-
Nanog) (Piazzolla et al., 2014) from Manuel Serrano (CNIO, Madrid) and
Konrad Hochedlinger (Harvard Stem Cell Institute). This is a double
transgenic line that carries the M2-rtTA gene inserted at the Rosa26 locus
and a cassette containing Nanog cDNA under the control of a doxycycline-
responsive promoter (tetO) inserted downstream of the Col1a1 locus. Mice
were genotyped by PCR of tail-tip DNA as previously described
(Hochedlinger et al., 2005; Piazzolla et al., 2014).
All mice used in this work were housed and maintained in the animal
facility at the Centro Nacional de Investigaciones Cardiovasculares (Madrid,
Spain) in accordance with national and European Legislation. Procedures
were approved by the CNIC Animal Welfare Ethics Committee and by the
Area of Animal Protection of the Regional Government of Madrid
(ref. PROEX 196/14).
In situ hybridization
Embryos were collected in cold PBS, transferred to 4% PFA, and fixed
overnight at 4°C. After washing, embryos were dehydrated in increasing
concentrations of PBS-diluted methanol (25%, 50%, 75% and 2X 100%).
In situ hybridization in wholemount embryos was performed as previously
described (Acloque et al., 2008; Ariza-McNaughton and Krumlauf, 2002).
Signal was developed with anti-digoxigenin-AP (Roche) and BM-Purple
(Roche). Images were acquired with a Leica MZ-12 dissecting microscope.
Primers used for the generation of probes are detailed in Table S2. The
expansion of Pou3f1 expression into posterior territories was scored on
images of embryos after wholemount in situ. For this, embryos were divided
vertically by an imaginary line that separated anterior from posterior halves
of the epiblast. If Pou3f1 expression extended into the posterior half, it was
scored as a phenotype.
Statistical analysis
Statistical analysis was performed with the use of two-tailed Student’s
unpaired t-test analysis (when the statistical significance of differences
between two groups was assessed). Fisher’s exact test was performed for
analysis of contingency tables containing the data of the deleted genotypes
and expanded phenotypes. Prism software version 7.0 (GraphPad Inc.) was
used for representation and statistical analysis. Enriched functional
categories in the mouse gene atlas score was calculated using Enrichr
(Chen et al., 2013; Kuleshov et al., 2016).
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K. S., Do, J. T. and Schöler, H. R. (2014). Establishment of a primed pluripotent
epiblast stem cell in FGF4-based conditions. Sci. Rep. 4, 7477. doi:10.1038/
srep07477
Kalkan, T. and Smith, A. (2014). Mapping the route from naive pluripotency to
lineage specification. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 369, 20130540.
doi:10.1098/rstb.2013.0540
Kuleshov, M. V., Jones, M. R., Rouillard, A. D., Fernandez, N. F., Duan, Q.,
Wang, Z., Koplev, S., Jenkins, S. L., Jagodnik, K. M., Lachmann, A. et al.
(2016). Enrichr: a comprehensive gene set enrichment analysis web server 2016
update. Nucleic Acids Res. 44, W90-W97. doi:10.1093/nar/gkw377
Li, B. and Dewey, C. N. (2011). RSEM: accurate transcript quantification from RNA-
Seq datawith or without a reference genome.BMCBioinformatics 12, 323. doi:10.
1186/1471-2105-12-323
Lopez-Jimenez, E., Sainz de Aja, J., Badia-Careaga, C., Barral, A., Rollan, I.,
Rouco, R., Santos, E., Tiana, M., Victorino, J., Sanchez-Iranzo, H. et al.
(2019). Pluripotency factors regulate the onset of Hox cluster activation in the early
embryo. BioRxiv 564658. doi:10.1101/564658
Martin, M. (2011). Cutadapt removes adapter sequences from high-throughput
sequencing reads. EMBnet. J. 17, 10. doi:10.14806/ej.17.1.200
Martin Gonzalez, J., Morgani, S. M., Bone, R. A., Bonderup, K., Abelchian, S.,
Brakebusch, C. and Brickman, J. M. (2016). Embryonic stem cell culture
conditions support distinct states associated with different developmental stages
and potency. Stem Cell Reports 7, 177-191. doi:10.1016/j.stemcr.2016.07.009
Mendjan, S., Mascetti, V. L., Ortmann, D., Ortiz, M., Karjosukarso, D. W., Ng, Y.,
Moreau, T. and Pedersen, R. A. (2014). Cell stem cell article NANOG and
CDX2 pattern distinct subtypes of humanmesoderm during exit from pluripotency.
Stem Cell 15, 310-325. doi:10.1016/j.stem.2014.06.006
Mohammed, H., Hernando-Herraez, I., Savino, A., Scialdone, A., Macaulay, I.,
Mulas, C., Chandra, T., Voet, T., Dean, W., Nichols, J. et al. (2017). Single-cell
landscape of transcriptional heterogeneity and cell fate decisions during mouse
early gastrulation. Cell Rep. 20, 1215-1228. doi:10.1016/j.celrep.2017.07.009
Morgani, S., Nichols, J. and Hadjantonakis, A. K. (2017). The many faces of
Pluripotency: in vitro adaptations of a continuum of in vivo states. BMC Dev Biol
17, 7. doi:10.1186/s12861-017-0150-4
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Supplementary Figures 
Fig. S1: Principal Component Analysis of the RNA-seq samples of early naïve to 
primed differentiation of Nanog KO and control ES cells. Component 1 (horizontal 
axis, 43% of variability explained) separates samples according to their genotype, while 
component 2 (vertical axis, 26% of variability explained) separates samples by time of 
differentiation (from 0h to 24h). 
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 Fig. S2. Combined analysis of the RNA-seq datasets. (A, B) Graphic representation 
of the correlation in separate single cell E6.5 embryo RNA-seq samples (P0 to P11) from 
Mohammed et al (2017), in blue, and Scialdone et al. (2016), in red, of Nanog with 
Pou3f1 (A) and Sox2 (B). Expression values are expressed in Log2CPM. (C, D) Enrichr 
results of Jansen Tissue Gene set library for genes whose expression is negatively (C) 
or positively (D) correlated with Nanog in E6.5 single cell RNA-seq datasets. (E) Bright 
field images of freshly dissected E9.5 Nanogtg embryos treated (+dox) or untreated (-
dox) with doxycycline from E6.5. White arrows indicate the craniofacial defects observed 
upon Nanog expression. Scale bar, 500µm.  
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Fig. S3. Expression of selected markers during posterior neural differentiation of 
ES cells. Expression of Nanog and neural markers, as quantified by RT-qPCR, during 6 
days of differentiation to posterior neural fate of Nanogtg ES cells with (+dox, blue) or 
without (-dox, gray) doxycycline. n=3 at each time point; *, p<0.01; **, p<0.001; ***, 
p<0.0001, ****,p<0.00001, by student’s t-test. 
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 Fig. S4: Deletion of NANOG bound genomic regions from the Pou3f1 locus. 
Sequence (right) of the genomic regions (A, -9kb; B, -11.5kb; C, +9kb) from the Pou3f1 
locus showing NANOG binding as determined by ChIP-seq by from Murakami et al. 
(2016), and PCR genotyping of single embryos (left) showing the wild type and the 
corresponding deleted bands by gel electrophoresis. 1kb Ladder molecular weight 
marker is shown on the left of the gels. 
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